A Large Institutional Study on Outcomes and Complications after Transcatheter Closure of a Perimembranous-Type Ventricular Septal Defect in 890 Cases

被引：1

作者：

Liu, Jun ^{[1
]}

Wang, Zhen ^{[1
]}

Gao, Lei ^{[1
]}

Tan, Hui-Lian ^{[1
]}

Zheng, Qinghou ^{[1
]}

Zhang, Mi-Lin ^{[1
]}

机构：

[1] Hebei Med Univ, Affiliated Hosp 1, Dept Cardiol, Shijiazhuang 050031, Hebei Province, Peoples R China

来源：

ACTA CARDIOLOGICA SINICA | 2013年 / 29卷 / 03期

关键词：

Complication; Interventional therapy; Ventricular septal defect; MEMBRANOUS VSD OCCLUDER; PERCUTANEOUS CLOSURE; DEVICE CLOSURE; SURGICAL CLOSURE; HEART-BLOCK; EXPERIENCE; IMMEDIATE; REGISTRY;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Purpose: To investigate the incidence, cause, and prevention of complications associated with interventional therapy for perimembranous ventricular septal defects (pmVSDs). Methods: A retrospective analysis was performed on 890 patients with pmVSDs after interventional therapy. The complications were then analyzed by electrocardiography and echocardiography during or after interventional therapy. During the follow-up period of 12-52 (mean of 26.9 +/- 21.6) months, the technical success rate was 97.9% (871/890). Results: The incidence of serious complication was 1.12% (10/890), including five cases of third-degree atrioventricular block, two of severe tricuspid valve regurgitation, one of cerebral infarction in the basal ganglia area, and two of femoral artery thrombosis. No death was reported during patient follow-up. Conclusions: Transcatheter closure of pmVSDs in selected patients was found to be effective and safe.

引用

页码：271 / 276

页数：6

共 35 条

[11] Transcatheter closure of perimembranous ventricular septal defects using the new amplatzer membranous VSD occluder - Results of the US phase I trial [J].